Výsledky vyhledávání - "Haruka Kanaoka"

Akademický článek

Pegfilgrastim-induced vasculitis of the subclavian and basilar artery complicated by subarachnoid hemorrhage in a breast cancer patient: a case report and review of the literature

Autor: Yukiko Seto, Nobuyoshi Kittaka, Azusa Taniguchi, Haruka Kanaoka, Satomi Nakajima, Yuri Oyama, Hiroki Kusama, Noriyuki Watanabe, Saki Matsui, Minako Nishio, Fumie Fujisawa, Koji Takano, Hideyuki Arita, Takahiro Nakayama

Publikováno v: Surgical Case Reports, Vol 8, Iss 1, Pp 1-10 (2022)

Abstract Background Pegfilgrastim (PEG) is a sustained-duration pegylated form of filgrastim, a granulocyte-colony stimulating factor agent that is widely used as prophylaxis against febrile neutropenia during chemotherapy. We report the case of a br

Externí odkaz: https://doaj.org/article/c06cbb992957436aa8b3dd3d5e8dedb8

Zobrazit plný text záznamu

Abstract P5-12-02: Germline variants detected by next-generation sequencing-based multigene panel testing in patients with suspected hereditary breast cancer at a University Hospital in Japan

Publikováno v: Cancer Research. 83:P5-12

Background: The usefulness of prophylactic surgery and surveillance for hereditary breast cancer has been demonstrated, and germline testing for BRCA1 and BRCA2 had been covered by insurance since 2020 in Japan. In addition to BRCA1 and BRCA2, severa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bf273d6862f76b71d4467f82c116682b
https://doi.org/10.1158/1538-7445.sabcs22-p5-12-02

Zobrazit plný text záznamu

Total Lesion Glycolysis Levels as Predictive Indicators in Patients With Metastatic and Recurrent Breast Cancer Undergoing Endocrine Therapy With or Without CDK4/6 Inhibitor

Autor: Hiromi, Ozawa, Tomoko, Higuchi, Yukie, Fujimoto, Ayako, Bun, Reiko, Fukui, Haruka, Kanaoka, Masayuki, Nagahashi, Kazuhiro, Kitajima, Koichiro, Yamakado, Yasuo, Miyoshi

Publikováno v: Anticancer Research. 42:4813-4824

Endocrine therapy (ET) with or without CDK4/6 inhibitors is the primary treatment choice for patients with estrogen receptor (ER)-positive and HER2-negative subtype of metastatic breast cancer (MBC). We examined the metabolic parameters identified us

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa51cee0fac1924d9fc81927d0c05f28
https://doi.org/10.21873/anticanres.15986

Zobrazit plný text záznamu

Absolute Lymphocyte Count Is an Independent Prognostic Factor for ER-positive HER2-negative Advanced Breast Cancer Patients Treated With CDK4/6 Inhibitors

Autor: Haruka, Kanaoka, Masayuki, Nagahashi, Yusa, Atake, Akira, Hattori, Ayako, Bun, Reiko, Fukui, Hiromi, Ozawa, Yukie, Fujimoto, Tomoko, Higuchi, Keiko, Natori, Michiko, Imamura, Keiko, Murase, Yuichi, Takatsuka, Yasuo, Miyoshi

Publikováno v: Anticancer Research. 42:4867-4878

The aim of this study was to elucidate the clinical significance of peripheral blood biomarkers, including absolute lymphocyte count (ALC), neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR) and C-reactive protein (CRP) in patie

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::50f426ef64fbd952015faad93b71e572
https://doi.org/10.21873/anticanres.15992

Zobrazit plný text záznamu

Abstract P4-07-26: Clinical impact of tumor infiltrating lymphocytes and neutrophil-lymphocyte ratio in estrogen receptor-positive/HER2-negative breast cancer patients with high 21-gene signature recurrence scores

Autor: Haruka Kanaoka, Masayuki Nagahashi, Eri Ishikawa, Ayako Bun, Reiko Fukui, Hiromi Ozawa, Tomoko Higuchi, Keiko Natori, Michiko Imamura, Yuichi Takatsuka, Yasuo Miyoshi

Publikováno v: Cancer Research. 82:P4-07

Background: Many guidelines recommended multi-gene assays to determine an indication of postoperative chemotherapy for estrogen receptor-positive (ER+)/HER2-negative (HER2−) breast cancer patients. The 21-gene signature assay (Oncotype DX) is one s

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::651ed30fa543096fb5b139064347a8fc
https://doi.org/10.1158/1538-7445.sabcs21-p4-07-26

Zobrazit plný text záznamu

Risk of Abemaciclib-induced Liver Injury in Hormone Receptor-positive, HER2-negative Metastatic Breast Cancer: A Retrospective Analysis

Autor: AZUSA TANIGUCHI, NOBUYOSHI KITTAKA, HARUKA KANAOKA, SATOMI NAKAJIMA, YURI OYAMA, YUKIKO SETO, AI SOMA, HIROKI KUSAMA, NORIYUKI WATANABE, SAKI MATSUI, MINAKO NISHIO, FUMIE FUJISAWA, TAKAHIRO NAKAYAMA

Publikováno v: Anticancer research. 42(12)

The efficacy of endocrine therapy combined with abemaciclib for hormone receptor-positive, HER2-negative metastatic breast cancer has been established through pivotal clinical trials. However, abemaciclib-induced liver injury (AILI) can be a cause fo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ccc485250c33acf7b87e04c1c9ab3f0
https://pubmed.ncbi.nlm.nih.gov/36456126

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání